Melatonin prevents learning disorders in brain-lesioned newborn mice

Neuroscience

Volumn 150, Issue 3, 2007, Pages 712-719

  Bouslama, M ^a,b   Renaud, J ^a,b   Olivier, P ^a,b   Fontaine, R H ^a,b   Matrot, B ^a,b   Gressens, P ^a,b   Gallego, J ^a,b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

conditioning; excitotoxicity; gray matter; neuroprotection; prematurity; white matter

Indexed keywords

IBOTENIC ACID; MELATONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INJURY; COGNITION; CONTROLLED STUDY; EXCITOTOXICITY; FEMALE; GRAY MATTER; HISTOLOGY; LEARNING DISORDER; MEMORY; MOUSE; NEUROPROTECTION; NEWBORN; NONHUMAN; ODOR; PERINATAL PERIOD; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; SENSORIMOTOR FUNCTION; TACTILE STIMULATION; VOCALIZATION; WHITE MATTER;

ANIMALS; ANIMALS, NEWBORN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; EPILEPSY, TONIC-CLONIC; EXCITATORY AMINO ACID AGONISTS; FEMALE; IBOTENIC ACID; LEARNING DISORDERS; MELATONIN; MICE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; ODORS; PHYSICAL STIMULATION; TOUCH; VOCALIZATION, ANIMAL;

EID: 36749060208     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.09.030     Document Type: Article

References (34)

1. Bersani G., and Garavini A. Melatonin add-on in manic patients with treatment resistant insomnia. Prog Neuropsychopharmacol Biol Psychiatry 24 (2000) 185-191
2. Bouslama M., Chauviere L., Fontaine R.H., Matrot B., Gressens P., and Gallego J. Treatment-induced prevention of learning deficits in newborn mice with brain lesions. Neuroscience 141 (2006) 795-801
3. Bouslama M., Durand E., Chauviere L., Van den Bergh O., and Gallego J. Olfactory classical conditioning in newborn mice. Behav Brain Res 161 (2005) 102-106
4. Branchi I., Santucci D., and Alleva E. Ultrasonic vocalisation emitted by infant rodents: a tool for assessment of neurobehavioural development. Behav Brain Res 125 (2001) 49-56
5. Dommergues M.A., Patkai J., Renauld J.C., Evrard P., and Gressens P. Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 47 (2000) 54-63
6. Filley C.M. The behavioral neurology of cerebral white matter. Neurology 50 (1998) 1535-1540
7. Fox W.M. Reflex-ontogeny and behavioural development of the mouse. Anim Behav 13 (1965) 234-241
8. Gitto E., Reiter R.J., Sabatino G., Buonocore G., Romeo C., Gitto P., Bugge C., Trimarchi G., and Barberi I. Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment. J Pineal Res 39 (2005) 287-293
9. Gitto E., Romeo C., Reiter R.J., Impellizzeri P., Pesce S., Basile M., Antonuccio P., Trimarchi G., Gentile C., Barberi I., and Zuccarello B. Melatonin reduces oxidative stress in surgical neonates. J Pediatr Surg 39 (2004) 184-189 discussion 184-189.
10. Gordon N. The therapeutics of melatonin: a paediatric perspective. Brain Dev 22 (2000) 213-217
11. Gressens P., Marret S., Hill J.M., Brenneman D.E., Gozes I., Fridkin M., and Evrard P. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. J Clin Invest 100 (1997) 390-397
12. Gressens P., Marret S., Martin J.L., Laquerriere A., Lombet A., and Evrard P. Regulation of neuroprotective action of vasoactive intestinal peptide in the murine developing brain by protein kinase C and mitogen-activated protein kinase cascades: in vivo and in vitro studies. J Neurochem 70 (1998) 2574-2584
13. Groves P.M., and Thompson R.F. Habituation: a dual-process theory. Psychol Rev 77 (1970) 419-450
14. Hack M., Taylor H.G., Drotar D., Schluchter M., Cartar L., Andreias L., Wilson-Costello D., and Klein N. Chronic conditions, functional limitations, and special health care needs of school-aged children born with extremely low-birth-weight in the 1990s. JAMA 294 (2005) 318-325
15. Hintz S.R., Kendrick D.E., Vohr B.R., Poole W.K., and Higgins R.D. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999. Pediatrics 115 (2005) 1645-1651
16. Husson I., Mesples B., Bac P., Vamecq J., Evrard P., and Gressens P. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol 51 (2002) 82-92
17. Husson I., Rangon C.M., Lelievre V., Bemelmans A.P., Sachs P., Mallet J., Kosofsky B.E., and Gressens P. BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge. Cereb Cortex 15 (2005) 250-261
18. Ikonomidou C., Mosinger J.L., Salles K.S., Labruyere J., and Olney J.W. Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity. J Neurosci 9 (1989) 2809-2818
19. Ikonomidou C., Price M.T., Mosinger J.L., Frierdich G., Labruyere J., Salles K.S., and Olney J.W. Hypobaric-ischemic conditions produce glutamate-like cytopathology in infant rat brain. J Neurosci 9 (1989) 1693-1700
20. Jan J.E., Wasdell M.B., Freeman R.D., and Bax M. Evidence supporting the use of melatonin in short gestation infants. J Pineal Res 42 (2007) 22-27
21. Johnston M.V. Excitotoxicity in perinatal brain injury. Brain Pathol 15 (2005) 234-240
22. Keselman H.J., and Keselman J.C. The analysis of repeated measures designs in medical research. Stat Med 3 (1984) 185-195
23. Laudenbach V., Calo G., Guerrini R., Lamboley G., Benoist J.F., Evrard P., and Gressens P. Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain. J Clin Invest 107 (2001) 457-466
24. Marlow N., Wolke D., Bracewell M.A., and Samara M. Neurologic and developmental disability at 6 years of age after extremely preterm birth. N Engl J Med 352 (2005) 9-19
25. Marret S., Mukendi R., Gadisseux J.F., Gressens P., and Evrard P. Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol 54 (1995) 358-370
26. Naguib M., and Samarkandi A.H. The comparative dose-response effects of melatonin and midazolam for premedication of adult patients: a double-blinded, placebo-controlled study. Anesth Analg 91 (2000) 473-479
27. Northington F.J. Brief update on animal models of hypoxic-ischemic encephalopathy and neonatal stroke. ILAR J 47 (2006) 32-38
28. Olney J.W., Ikonomidou C., Mosinger J.L., and Frierdich G. MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain. J Neurosci 9 (1989) 1701-1704
29. Penev P.D., and Zee P.C. Melatonin: a clinical perspective. Ann Neurol 42 (1997) 545-553
30. Schaal B., Hummel T., and Soussignan R. Olfaction in the fetal and premature infant: functional status and clinical implications. Clin Perinatol 31 (2004) 261-285 vi-vii.
31. Tahraoui S.L., Marret S., Bodenant C., Leroux P., Dommergues M.A., Evrard P., and Gressens P. Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol 11 (2001) 56-71
32. Weiss M.D., Wasdell M.B., Bomben M.M., Rea K.J., and Freeman R.D. Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. J Am Acad Child Adolesc Psychiatry 45 (2006) 512-519
33. Welin A.K., Svedin P., Lapatto R., Sultan B., Hagberg H., Gressens P., Kjellmer I., and Mallard C. Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr Res 61 (2007) 153-158
34. Wood N.S., Costeloe K., Gibson A.T., Hennessy E.M., Marlow N., and Wilkinson A.R. The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age following extremely preterm birth. Arch Dis Child Fetal Neonatal Ed 90 (2005) F134-F140